No existe un lugar como el hogar. Diálisis Peritoneal en tiempos difíciles. ¿Qué no hemos entendido?

Palabras clave: Diálisis Peritoneal, Hemodiálisis, Desastres Naturales, Pandemia, Confinamiento.

Resumen

La Diálisis Peritoneal es una terapia igual o superior a la hemodiálisis, es costo-efectiva y ha permitido el soporte dialítico vital a poblaciones víctimas de desastres naturales. En las actuales circunstancias de pandemia y aislamiento social por el COVID 19, la diálisis peritoneal, al ser una terapia domiciliaria, reduce los riesgo de exposición para pacientes, cuidadores y equipos de atención, sin embargo, es una terapia subutilizada a nivel global. Al mostrar los beneficios de la diálisis peritoneal sobre la hemodiálisis y los desenlaces de esta en tiempos de desastre, se presenta como la mejor alternativa para estos tiempos de pandemia. Se llevó a cabo una revisión no sistemática de la literatura, en busca de los beneficios de la diálisis peritoneal vs hemodiálisis y sus desenlaces en situaciones de calamidad. En esta se incluyeron 75 artículos publicados entre1993 y marzo del 2020. Estos estudios muestran los múltiples beneficios de la diálisis peritoneal sobre la hemodiálisis y ser la mejor alternativa en situaciones de desastre. Por lo anterior concluimos que la diálisis peritoneal tiene significativos  beneficios sobre la hemodiálisis, entre estos una mayor supervivencia, especialmente en los dos primeros años, una menor velocidad en la tasa de perdida de la función renal residual, permite preservar los accesos vasculares, hay mayor supervivencia post trasplante, además de ser más económica y en situaciones de desastres naturales, como lo es esta pandemia, ha facilitado la continuidad de la atención y el soporte dialítico agudo o crónico para las víctimas.

Descargas

La descarga de datos todavía no está disponible.

Referencias

2018 USRDS Annual data report | Volume 2: ESRD In theUnited States. https://www.sciencedirect.com/journal/american-journal-of-kidney-diseases/vol/73/issue/3/suppl/S1

Atlas de la diabetes de la FID, novena edición 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133352_2406-IDF-ATLAS-SPAN-BOOK.pdf

Roberts M, Polkinghorne K, McDonald S, Ierino F. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis 2011;58:64–72

Wang A, Brimble K, Brunier G, Holt S, Jha V, Johnson D, et al. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors. Perit Dial Int 2015; 35:379–387

Andreu D, Hidalgo Miguel, Moreno Maria. La supervivencia de las personas sometidas a diálisis. EnfermNefrol [Internet]. 2013 Dic [citado 2020 Mar 27]; 16( 4 ): 278-280. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2254 28842013000400009&lng=es.

Pinares-Astete F, Meneses-Liendo V, Bonilla-Palacios J, Ángeles-Tacchino P, Cieza-Zevallo J. Supervivencia a largo plazo en pacientes con enfermedad renal crónica estadio 5 tratada por hemodiálisis en Lima, Perú. Acta MedPeru. 2018;35(1):20-7

Pérez M, Herrera N, Pérez E. Comportamiento de la mortalidad del adulto en hemodiálisis crónica. Rev. Arch Med Camagüey 2017;21:773-786

Krediet R, Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol 2012;6:451–460

Ronco C. The Rise of Expanded Hemodialysis. Blood Purif 2017;44:I–VIII

Marshall M, Polkinghorne K, Kerr P, Agar J. Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population. Am J KidneyDis. 2015;66(3):489-498

Fondo de Enfermedades de Alto Costo. Situación de la enfermedad renal crónica, la hipertensión arterial y la diabetes mellitus en Colombia. 2018

Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol DialTransplant 2013; 28: 2553–2569

https://www.cdc.gov/coronavirus/2019-ncov/faq-sp.html

file:///C:/Users/wckdnf02/Downloads/WHO-2019-nCoV-IHR_Quarantine-2020.2-eng%20(1).pdf

https://www.cdc.gov/coronavirus/2019-ncov/about/transmission-sp.html

http://jdmichel.blog.tdg.ch/archive/2020/03/18/covid-19-fin-de-partie-305096.html?fbclid=IwAR2yYZeL3rUa0GyQjpxKZLnGtDHKll3VHMv_FetVmZfDTZUjHUUbJoUNktg

Koo J, Cook A, Park M, Sun Y, Sun H, Tao Lim J, et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis 2020. Published Online March 23, 2020 https://doi.org/10.1016/ S1473-3099(20)30162-6

https://www.dhss.delaware.gov/dhss/dph/files/isolandquarpisp.pdf

Naicker S, Yang Ch, Hwang S, Liu B, Chen J and Jha V. The Novel Coronavirus 2019 Epidemic and Kidneys, Kidney International (2020), doi: https://doi.org/10.1016/ j.kint.2020.03.001.

Guan W, Ni Z, Hu Y, Liang W, Ou Ch, He J. et al. He et al. Clinical Characteristics of Coronavirus Disease 2019 in China. https://www.nejm.org/doi/pdf/10.1056/NEJMoa2002032

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients. doi: https://doi.org/10.1101/2020.02.18.20023242 medRxiv preprint.

Kidney Disease Improving Global Outcomes (KDIGO) CKD Work GroupKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013; 3: 1-150

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-272.

Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China. Available at https://www.medrxiv.org/content/10.1101/2020.02.24.20027201v2. Accessed 02 Mar 2020

Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX et al. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities. Am J Kidney Dis. 2018 Mar;71:344-351

Sanabria M, Muñoz J, Trillos C, Hernández G, Latorre C, Díaz CS, et al. Dialysis outcomes in Colombia (DOC) study: A comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia Kidney Int 2008; 73: S165–S172

Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant. 2012;27(9):3568-3575.

Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011;171:110–118

Marshall M. The benefit of early survival on PD versus HD—why this is (still) very important. Perit Dial Int. Epub ahead of print 2020 DOI: 10.1177/0896860819895177

Go A, Chertow G, Fan D, McCulloch Ch and Hsu Ch. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med 2004;351:1296-1305

Bargman J M, Thorpe K E and Churchill D N. Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study. J Am Soc Nephrol 2001; 12:2158-2162

Paniagua R, Amato D, Vonesh E, Correa Rotter R, Ramos A, Moran J et al. Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial. J Am Soc Nephrol. 2002; 13:1307-1320

Marrón B, Remón C, Pérez-Fontán M, Quirós P, Ortíz A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int 2008; 73: S42–S51

Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc EDTA 1983; 19: 397–403.

Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598–604.

Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA,et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556–564.

Misra M, Vonesh E, Van Stone J, Moore H, Prowant B, Nolph K. Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int 2001; 59: 754–763.

Lang S, Bergner A, Töpfer M, Schiffl H. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int 2001; 21: 52–57.

Jansen M, Hart A, Korevaar J, Dekker F, Boeschoten E, Krediet R; NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046–1053.

He L, Liu X, Li Z, Abreu Z, Malavade T, Lok CE, et al. Rate of decline of residual kindney function before and after the start of the peritoneal dialysis. Perit Dial Int 2016; 36(3):334–339

Van Biesen W, Dequidt C, Vanholder R, LameireN.. The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters. Adv Perit Dial 2002; 18: 44–48

Berlanga J, Marrón B, Reyero A, Caramelo C, Ortiz A. Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 2002; 22: 239–242.

Viglino G, Neri L, and Barbieri S. Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy. Kidney Int. 2008; 73: S52–S55

Pastan S, Soucie J, McClellan W. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620-626

Ethier J, Mendelssohn D, Elder S, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23:3219-3226

Perl J, Wald R, McFarlane P, Bargman J M. Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival. J Am Soc Nephrol. 2011;22:1113-1121

Coentrão L, Santos-Araújo C, Dias C, Neto R, Pestana M. Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study. BMC Nephrol 2012; 13: 88.

Kumar V, Sidell M, Jones J, Vonesh E. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int 2014; 86(5): 1016–1022.

Heaf J, Løkkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002;17:112-117

Molnar M, Mehrotra R, Duong U, Bunnapradist S, Lukowsky L, Krishnan M et al Dialysis Modality and Outcomes in Kidney Transplant Recipients. Clin J Am Soc Nephrol 2012;7: 332–341

Schwenger V, Döhler B, Morath C, Zeier M, Opelz G. The role of pretransplant dialysis modality on renal allograft outcome. Nephrol Dial Transplant 2011; 26: 3761–3766

Arrieta J. Evaluación económica del tratamiento sustitutivo renal (hemodiálisis, diálisis peritoneal y trasplante) en España. Nefrologia 2010;1(Supl Ext 1):37-47.

Pacheco A, Saffie A, Torres R, Tortella C, Cristian Llanos Ll, Vargas D, et al. Cost/utility study of peritoneal dialysis and hemodialysis in Chile. Perit Dial Int 2007; 27:359–363

Baboolal K, McEwan P, Sondhi S, Spiewanowsk P. The cost of renal dialysis in a UK setting—a multicentre study. Nephrol Dial Transplant 2008; 23: 1982–1989

Arrieta J, Rodríguez-Carmona A, Remón C, Pérez-Fontán M, Ortega F. Sánchez Tornero J et al. La diálisis peritoneal es la mejor alternativa coste-efectiva para la sostenibilidad del tratamiento con diálisis. Nefrologia 2011;31:505-13

Mendes M, Walker D, Sesso R, and Ferraz M . A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in São Paulo, Brazil. Perit Dial Int 2013; 33(3):304-315

Chui B, Manns B, Pannu N, Dong J, Wiebe N, Jindal K, et al. Health Care Costs of Peritoneal Dialysis Technique Failure and Dialysis Modality Switching. Am J Kidney Dis. 2012; 61:104-111.

Klarenbach S, Tonelli M, Chui B, Manns B. Economic evaluation of dialysis therapies. Nat Rev Nephrol. 2014; 10:644-52

Rubin H, Fink N, Plantinga L, Sadler J, Kliger A, Powe N. Patient Ratings of Dialysis Care With Peritoneal Dialysis vs Hemodialysis JAMA. 2004;291(6):697-703

Mapes D, Lopes A, Satayathum S, McCullough K, Goodkin D, Locatelli F et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003 Jul;64(1):339-49

The World Bank, Natural Hazards, UnNatural Disasters The Economics of Effective Prevention, 2010 The International Bank for Reconstruction and Development / The World Bank 1818 H Street NW Washington DC 20433 Telephone: 202-473-1000 Internet: www.worldbank.org

Pavlovic D, Jankovic N, Orlic L, Heinrich B. Dialysis patients: vulnerable group of patients, Kidney Int. 2010;77: 72; doi:10.1038/ki.2009.361

Cala S. Peritoneal dialysis in Croatia. Perit Dial Int. 2007;27:238-244.

Sanabria M, Devia M, Hernández G, Astudillo K, Trillos C, Uribe M et al; Outcomes of a Peritoneal Dialysis Program in Remote Communities Within Colombia Perit Dial Int. 2015 Jan-Feb; 35(1): 52–61. doi: 10.3747/pdi.2012.00301

Ronco C, Crepaldi C, Rosner MH. Remote Patient Management in Peritoneal Dialysis. ContribNephrol. Basel, Karger, 2019, vol 197, pp 73–83 (DOI: 10.1159/000496318), https://doi.org/10.1159/000496318

Bunch A, Vesga JI, Camargo D, Corzo L, Molano A, Devia M et al. Remote Automated Peritoneal Dialysis Management in Colombia Kidney Int Rep. 2019 Jun; 4(6): 873–876. doi: 10.1016/j.ekir.2019.03.017

Nangaku M, Akizawa T; Diary of a Japanese nephrologist during the present disaster, Kidney Int. 2011;79: 1037–1039. doi:10.1038/ki.2011.106

Kawabata C1, Hamanoue S2, Maekawa A2, Toyoda M2, Miyata A2, Uekihara S2., Communication with Peritoneal Dialysis Patients Post-Kumamoto Earthquake, Perit Dial Int. 2017 Jul-Aug;37(4):484-485

Ozener C1, Ozdemir D, Bihorac A. The impact of the earthquake in northwestern Turkey on the continuous ambulatory peritoneal dialysis patients who were living in the earthquake zone, Adv Perit Dial. 2000;16:182-185

China S. Management of Continuous Ambulatory Peritoneal Dialysis Patients in a Disaster: The Japanese Experience During the Kobe Earthquake. Ren Fail. 1997;19(5): 687-692

Kenney R. Emergency Preparedness Concepts for Dialysis Facilities: Reawakened after Hurricane Katrina. Clin J Am Soc Nephrol 2007;2: 809–813, doi: 10.2215/CJN.03971106

https://www.era-edta.org/en/covid-19-news-and-information/#toggle-id-14

Naicker S, Yang Ch, The Novel Coronavirus 2019 epidemic and kidneys, Kidney International (2020), https://doi.org/10.1016/j.kint.2020.03.001

https://www.theisn.org/covid-19

Stenvinkel P, Fouque D and Wanner Ch. Life/2020—the future of kidney disease, Nephrol Dial Transplant 2020;35: ii1–ii3, doi: 10.1093/ndt/gfaa028

Publicado
2020-11-09
Cómo citar
1.
Uribe Betancur JM, Molano Triviño AP. No existe un lugar como el hogar. Diálisis Peritoneal en tiempos difíciles. ¿Qué no hemos entendido?. Rev. Colomb. Nefrol. [Internet]. 9 de noviembre de 2020 [citado 23 de noviembre de 2020];8(1):87-108. Disponible en: https://revistanefrologia.org/index.php/rcn/article/view/428